Myriad Genetics | MYGN - Ebit


Myriad Genetics reported $-5.5M in EBIT for its fiscal quarter ending in March of 2025.





Ebit Change Date
Agilent USD 443M 66M Sep/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Bio-Rad Laboratories USD -418.8M 845.4M Sep/2025
Bruker USD 76.3M 7.6M Dec/2025
Danaher USD 1.5B 348M Dec/2025
Exact Sciences USD -25M 22.85M Sep/2025
Hologic USD 240.9M 12.1M Dec/2025
Illumina USD 256M 6M Dec/2025
J&J USD 5.11B 2.3B Dec/2025
Mettler Toledo International USD 351.93M 57.73M Dec/2025
Myriad Genetics USD -5.5M 11.1M Mar/2025
OraSure Technologies USD -6M 13.22M Sep/2024
Pacific Biosciences Of California USD -73.51M 338K Sep/2023
Quest Diagnostics USD 386M 0 Dec/2025
Quidel USD -37.3M 82.5M Dec/2025
Repligen USD 16.81M 10.85M Sep/2025
Revvity USD 145.83M 47.49M Dec/2025
Standard Biotools USD -32.89M 14.62M Sep/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Veracyte USD 23.11M 8.8M Sep/2025
Waters USD 270.52M 78.4M Dec/2025